Auspex Pharmaceuticals, Inc.

Ontogen Corporation

Other

Agouron Pharmaceuticals, Inc.

Acadia Pharmaceuticals Inc.

Sepehr Sarshar

Thomas George Gant

Adnan M Mjalli

Farid Bakir

Xiaodong Cao

Subramanian Marappan

Bruno Tse

Cris Davenport

Borcherng Hong

Henrik Sune Andersen

Steven Lee Bender

Sven Branner

Allen Borchardt

Soon Hyung Woo

Dilip Ramakant Bhumralkar

Mitchell David Nambu

Anna Maria Tempczyk-Russell

Shao Song Chu

Suzanne Pritchett Benedict

Larry Andrew Alegria

Zhengwei Peng

Claus Bekker Jeppesen

Michelle Yang

Zhong-Yi Chen

Robert Steve Kania

Arumugam Nagarajan

Adnan M M Mjalli

Kottani Rudresha

Niels Peter Hundahl Moeller

Vishal P Chavan

Chemical syntheses and medical uses of novel inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, for the treatment and/or management of psychotropic disorders, anxiety disorder, generalized anxiety disorder, depression, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, hot flashes, senile dementia, migraine, hepatopulmonary syndrome, chronic pain, nociceptive pain, neuropathic pain, painful diabetic retinopathy, bipolar depression, obstructive sleep apnea, psychiatric disorders, premenstrual dysphoric disorder, social phobia, social anxiety disorder, urinary incontinence, anorexia, bulimia nervosa, obesity, ischemia, head injury, calcium overload in brain cells, drug dependence, attention deficit hyperactivity disorder, fibromyalgia, irritable bowel syndrome, and/or premature ejaculation are described. 

Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity

Disclosed herein are substituted N-Aryl pyridinone fibrotic inhibitors and/or collagen infiltration modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof. 

Substituted N-aryl pyridinones

Chemical syntheses and medical uses of novel inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, for the treatment and/or management of psychotropic disorders, anxiety disorder, generalized anxiety disorder, depression, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, hot flashes, senile dementia, migraine, hepatopulmonary syndrome, chronic pain, nociceptive pain, neuropathic pain, painful diabetic retinopathy, bipolar depression, obstructive sleep apnea, psychiatric disorders, premenstrual dysphoric disorder, social phobia, social anxiety disorder, urinary incontinence, anorexia, bulimia nervosa, obesity, ischemia, head injury, calcium overload in brain cells, drug dependence, and/or premature ejaculation are described. 

Substituted N-Aryl pyridinones

The present disclosure is directed to modulators of GABAreceptors and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment and/or management of sleep disorders and/or for providing a patient in need with a hypnotic, anxiolytic or anti-convulsive effect are described. 

Preparation and utility of substituted imidazopyridine compounds with hypnotic effects

The present disclosure is directed to modulators of opiate- and/or NMDA receptors and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the use of such compounds for the treatment and/or management of pain, anxiety, neurodegeneration, drug dependence, coughing, muscular tension, and/or glaucoma and any other condition in which it is beneficial to modulate an opiate- and/or NMDA receptor. 

Preparation and utility of opioid analgesics

Disclosed herein are substituted pyrimidine-based endothelin modulators of Formula I, processes of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof. 

Substituted thiophenes

Disclosed herein are substituted amino alcohol anti-mycobacterial agents and/or chelation therapy agents of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof. 

Substituted amino alcohols

Growing community of inventors

Cardiff by the Sea, CA, United States of America

Sepehr Sarshar